Publications
- Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis2009 | First Faculty of Medicine
- Interferon beta-1a combination with azathioprine and low-dose steroids (ASA study) for relapsing-remitting multiple sclerosis clinical and MRIdata from 2-years double blind, randomised, placebo controled studyPublication without faculty affiliation
- Intramuscular Interferon beta-1a, Azathioprine, and corticosteroid combination therapy in patients with relapsing-remitting multiple sclerosis: 5-year clinical efficacy resultsPublication without faculty affiliation
- Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: Results of a 5-year follow-up study2013 | First Faculty of Medicine
- Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years2013 | First Faculty of Medicine
- Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years : A Longitudinal Study2013 | First Faculty of Medicine
- Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis2012 | First Faculty of Medicine
- Serious Complication of Percutaneous Angioplasty with Stent Implantation in so Called "Chronic Cerebrospinal Venous Insufficiency" in Multiple Sclerosis Patient2012 | First Faculty of Medicine
- Clinical correlates of grey matter pathology in multiple sclerosis2012 | First Faculty of Medicine
- Early predictors of non-response to interferon in multiple sclerosis2012 | First Faculty of Medicine
Loading network view...